Lilly vs Pfizer: Obesity Race Reaches Market Highs
Lilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...
This guide explains how to identify price-weighted indexes and what characteristics indicate a price-based method.
25,721 articlesLilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...
AI disruption is rattling markets, but Bitcoin still has unique safeguards. This guide explains why bitcoin safe from...
As AI shifts the tech landscape, Microsoft sits at the center of the action. This guide breaks down whether will micr...
As NetApp gears up for 2026 earnings, investors should focus on cloud services growth, margins, and free cash flow. T...
Cantor Fitzgerald analyst CJ Muse contends memory supply will tighten into 2027, a view that could drive Micron's ear...
Bank of America issues two contrasting Buy ratings, backing Tesla’s autonomy roadmap and GM’s truck-led profitability...
Spotlighting two strong growth names that could exceed Summit Therapeutics in a year. Learn the catalysts, risks, and...
Rivian shares jumped about 8% amid a crucial R2 production debut and rising software revenue, even as peers Tesla and...
As AI demand climbs, power reliability becomes the bottleneck. This energy stock helping power AI offers a way to inv...
A sharp February move put Remitly Global in the spotlight. This article breaks down the catalysts behind the rally, t...
A growing claim about Chrome downloads a 4GB AI model and quietly reinstalls it if deleted. This article explains wha...
Petco's WOOF ticker hints at a pet retailer balancing stores, services, and digital growth. This investor guide break...